Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis.
Rezkitha YAA, Panenggak NSR, Lusida MI, Rianda RV, Mahmudah I, Pradana AD, Uchida T, Miftahussurur M.
Rezkitha YAA, et al.
J Med Life. 2024 Jan;17(1):4-14. doi: 10.25122/jml-2023-0269.
J Med Life. 2024.
PMID: 38737656
Free PMC article.
Review.
Several markers show promising potential, including the methylation of vimentin (VIM), syndecan-2 (SDC2), and septin 9 (SEPT9). However, their application as screening and diagnostic tools, particularly for early-stage CRC, has not been fully optimized, and t …
Several markers show promising potential, including the methylation of vimentin (VIM), syndecan-2 (SDC2), and septin 9 (SEP …